FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 2000607 · Received February 2, 2011

Report

Report Number
2027969-2011-00245
Event Type
Malfunction
Date Received
February 2, 2011
Date of Event
January 12, 2011
Report Date
February 2, 2011
Manufacturer
ALERE SAN DIEGO, INC.
Product Code
GJS
PMA / PMN Number
021923
Removal / Correction Number
NI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

INRATIO PRECISION DATA PROVIDED BY END-USER. 1ST INR: 7.5; 2ND INR: 2.0; 3RD INR: 1.7; MEAN: 3.73; SD: 3.27; %CV: 87.47. ANALYSIS OF CUSTOMER'S DATA REVEALED THAT REPEATED INRATIO TEST RESULT COMPARISON DID NOT MEET PRECISION CRITERIA. CUSTOMER'S RESULTS ARE CONSIDERED DISCREPANT BEYOND THE CONTEXT OF THE DOCUMENTED VARIABILITY FOR INR TESTING. NO PRODUCT IS EXPECTED TO BE RETURNED. RETAINED STRIP TESTING FROM A PREVIOUS CASE REVEALED THAT RESULT COMPARISONS MET PRECISION CRITERIA. INVESTIGATION RESULTS FROM A PREVIOUS CASE: DONOR 1: 1ST INR: 3.1; 2ND INR: 3.1; 3RD INR: 3.0; MEAN: 3.07; SD: 0.06; %CV: 1.88. DONOR 2: 2.5; 2.4; 2.4; 2.43; 0.06; 2.37. SINCE BOTH DONORS ARE BELOW 16% CV, STRIP LOT #235739 MET CRITERIA FOR PRECISION. NO FURTHER INVESTIGATION WILL BE PURSUED AT THIS TIME. (B)(4). DUE TO THIS LOW OCCURRENCE RATE, BELOW THE ACTION THRESHOLDS MONITORED BY QA FOR CORRECTIVE ACTION (B)(4), NO FURTHER ACTION IS REQUIRED AT THIS TIME. THIS ISSUE WILL BE SUBJECT TO TRACKING AND TRENDING. NO CORRECTIVE ACTION REQUIRED AT THIS TIME AS NO PRODUCT DEFICIENCY WAS ESTABLISHED.

Description of Event or Problem · 1

CALLER ALLEGED IMPRECISION WITH INRATIO METER. RESULTS AS FOLLOWS: DATE: (B)(6) 2011, INRATIO: >7.5 (SN: (B)(4), TECHNICIAN 1), INRATIO: 2.0 (SN: (B)(4), TECHNICIAN 2), INRATIO: 1.7 (SN: (B)(4), TECHNICIAN 2). PT'S THERAPEUTIC RANGE: 2-3 INR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC. 100139 235793

Patients

Seq Age Sex Outcome Treatment
1 NI